menu
ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

DMD DIGITAL HEALTH (APTOF)
0.1736 0 (-4.88%)  11-30 13:51
Open: 0 Prev Close: 0.1736
High: 0 Low: 0
Volume: 0 Market Cap: 35M
Year High: 0.307 Year Low: 0
Stock Technical Analysis
Overall       
Targets Six months: 0.2197    One year: 0.2301
Supports Support1: 0.1736   Support2: 0.1444
Resistances Resistance1: 0.1881    Resistance2: 0.1970 
Pivot Point 0.1736 
Moving Averages MA(5): 0.1736      MA(20): 0.1736 

MA(100): 0.1973  -1     MA(250):  
MACD MACD(12,26): -0.001      Signal(12,26,9): -0.002 
Stochastic Oscillator %K(14,3):       %D(3):  
RSI RSI(14): 19.052 
52-Week High: 0.2830  Low: 0.1580  Change(%): -42
Average Volume(K) 3-Month:   10-Days: 0
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is below its mid-term; and below long term moving averages. From the relationship between price and moving averages; we can see that: this stock is NEUTRAL in short-term; and BEARISH in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed Bollinger Bands are 0% narrower than normal.

Stoxline

Stock Chart

Top 100 stocks

Stock News
Aptilon announces Company name change to DMD Digital Health Connections Group Inc.
Wed, 13 Aug 2014 20:26:15 GMT

Aptilon Announces Acquisition of Direct Medical Data, LLC and BLM Incorporated ...
Fri, 18 Sep 2009 19:07:03 GMT

With An ROE Of 53.21%, Has DMD Digital Health Connections Group Inc's (TSXV ...
Mon, 23 Oct 2017 15:20:59 GMT

Game Changers 2017: DMD
Thu, 18 May 2017 19:03:23 GMT

Sarepta Wins Controversial FDA Approval for First DMD Drug
Mon, 19 Sep 2016 15:16:58 GMT

-DI Above +DI on Shares of Dmd Digital Health Connections (APTOF)
Wed, 04 Oct 2017 17:37:30 GMT

Families, lawmakers demand transparency for $89000 drug
Thu, 16 Feb 2017 19:18:27 GMT

The families that fought for controversial new drug
Tue, 04 Oct 2016 19:07:30 GMT

Can CRISPR deliver real progress in Duchenne muscular dystrophy?
Mon, 27 Feb 2017 22:14:37 GMT

FDA approves Duchenne muscular dystrophy drug
Thu, 09 Feb 2017 21:04:22 GMT